Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Taxane-induced Peripheral Neuropathy 1Sarcopenia 1Peripheral Nervous System Diseases 1Colonic Neoplasms 1

Interventions

pembrolizumab 551Specimen Handling 465Carboplatin 441Magnetic Resonance Spectroscopy 430Cyclophosphamide 412Cisplatin 397Radiotherapy 313Gemcitabine 309Bevacizumab 307Paclitaxel 294Biopsy 261Drug Therapy 249Capecitabine 242Oxaliplatin 239fludarabine 237Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 187Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 146durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Gloves, Surgical × Clear all
NCT07285356 2025-12-16

GLOX-PEN

AC Camargo Cancer Center

Phase NA Recruiting
84 enrolled
Gastrointestinal

Colonic Neoplasms, Peripheral Nervous System Diseases, Sarcopenia

NCT06464536 2025-05-16

ComPrendo

St.Gallen University of Applied Sciences

Phase NA Recruiting
114 enrolled

Taxane-induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡